Search Results 481-490 of 14796 for anti-TNF drugs

  1. Mayo Clinic expert talks benefits, risks of experimental Alzheimer's drug

    An experimental drug for Alzheimer's disease shows promise to slow the progression of the diseas. A Mayo Clinic Neurologist gives perspective.

  2. Mayo Clinic Comprehensive Cancer Center Research

    Research in the Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center focuses on signaling pathways, anti-cancer drugs, ...

  3. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

  4. Infliximab-Abda (Intravenous Route) Proper Use - Mayo Clinic

    Ask your doctor if you have questions. You may also receive other medicines (eg, allergy medicine, fever medicine, steroids) to help prevent possible unwanted ...

  5. Antifungal, Azole (Vaginal Route) Precautions - Mayo Clinic

    Vaginal medicines usually will come out of the vagina during treatment. To keep the medicine from getting on your clothing, wear a minipad or sanitary napkin.

  6. Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) - Mayo Clinic

    About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...

  7. Fluticasone (Nasal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Pentostatin (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Epirubicin (Intravenous Route) Precautions - Mayo Clinic

    Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 3 months after the last dose.

  10. Fam-Trastuzumab Deruxtecan-Nxki (Intravenous Route) Description and Brand Names - Mayo Clinic

    ... anti-HER2 breast cancer treatment for metastatic disease or have breast cancer that has come back during or within 6 months of completing treatment for ...